Clinical Trial Update: Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ezetimibe/atorvastatin (MK-0653C) versus atorvastatin alone in Chinese participants with hypercholesterolemia. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2023-02-08